Axis I psychiatric disorders such as depressive disorder, anxiety disorder, adjustment disorder, and premenstrual disorders are serious disabling illnesses. Newer treatments for these disorders include selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), and other second-generation drugs. The purpose of this review is to help policymakers and clinicians make informed choices about the use of SSRIs and newer antidepressants.
Drug class review on second generation antidepressants
Final report [Internet]